Race, Pediatric Mental Health and Psychopharmacology
Shashank V Joshi, MD, FAAP, DFAACAP, is Professor of Psychiatry, Pediatrics and Education at the Stanford University School of Medicine and Graduate School of Education (by courtesy), Director of School Mental Health at Lucile Packard Children’s Hospital, and a Faculty Advisor at the Center for Comparative Studies in Race and Ethnicity (CCSRE). Among many roles at Stanford, he currently serves on the HumBio Curriculum Committee, Advisory Board for Stanford Introductory Studies (SIS), and VPUE Undergraduate Advisory Council. Dr. Joshi’s scholarly work focuses on school mental health, suicide prevention in school settings, cultural aspects of pediatric health, doctor-parent-teacher collaboration in medical care, and well-being promotion in youth and young adults. He is the lead author of the K12 Toolkit for Mental Health Promotion and Suicide Prevention used by the California Department of Education, and co-editor of the recent book Partnerships for Mental Health: A Guide to Community and Academic Collaboration [Philadelphia, Springer (2015)]. His current book project is an international collaboration entitled, Thinking About Prescribing: The Psychology of Psychopharmacology with Diverse Youth & Young Adults.
Takesha J. Cooper, M.D., M.S. is an associate clinical professor of psychiatry at the UC Riverside School of Medicine and a double board certified child, adolescent and adult psychiatrist. She also serves as an Equity Advisor, Program Director of the Psychiatry Residency Training Program, Vice Chair of Education and Chair of the Admissions Committee. She a member of the American College of Psychiatrists, Association of Academic Psychiatry, American Academy of Child and Adolescent Psychiatrists, and the American Psychiatric Association. Her interests include equity, diversity and inclusion within medicine and pediatric mental health. She participated in a National Institute of Mental Health-sponsored study of systematic treatment enhancement for bipolar disorder, a large-scale longitudinal project designed to improve the effectiveness of treatment for bipolar disorder.